Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Halloran

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Clinical Endocrinology and Metabolism|November 1, 1991
1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trialD Grady, B Halloran, S Cummings, et al.
Endocrinology|September 29, 1998
Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized ratsR T Turner, G L Evans, J M Cavolina, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding proteinD D Bikle, E Gee, B Halloran, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
The skeletal structure of insulin-like growth factor I-deficient miceD Bikle, S Majumdar, A Laib, et al.
Investigational New Drugs|May 17, 2022
A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemiaMargaret T Kasner, Molly B Halloran, Jonathan Pan, et al.
Endocrinology|December 1, 2007
Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopeniaJ Peng, M Bencsik, A Louie, et al.
Scientific Reports|February 12, 2016
Dried plum diet protects from bone loss caused by ionizing radiationA-S Schreurs, Y Shirazi-Fard, M Shahnazari, et al.
Pigment Cell & Melanoma Research|October 27, 2010
PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomasJohn T Lee, Ling Li, Patricia A Brafford, et al.
BMC Medical Research Methodology|July 9, 2025
A framework for clinical care pathway renewal: an example from inflammatory bowel diseaseK D Chappell, L Olayinka, R Sutton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cellsClemens Krepler, Srinivas K Chunduru, Molly B Halloran, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Clinical Endocrinology and Metabolism|November 1, 1991
1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trialD Grady, B Halloran, S Cummings, et al.
Endocrinology|September 29, 1998
Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized ratsR T Turner, G L Evans, J M Cavolina, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding proteinD D Bikle, E Gee, B Halloran, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 5, 2002
The skeletal structure of insulin-like growth factor I-deficient miceD Bikle, S Majumdar, A Laib, et al.
Investigational New Drugs|May 17, 2022
A phase Ib dose escalation study of oral monotherapy with KX2-391 in elderly patients with acute myeloid leukemiaMargaret T Kasner, Molly B Halloran, Jonathan Pan, et al.
Endocrinology|December 1, 2007
Conditional expression of a Gi-coupled receptor in osteoblasts results in trabecular osteopeniaJ Peng, M Bencsik, A Louie, et al.
Scientific Reports|February 12, 2016
Dried plum diet protects from bone loss caused by ionizing radiationA-S Schreurs, Y Shirazi-Fard, M Shahnazari, et al.
Pigment Cell & Melanoma Research|October 27, 2010
PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomasJohn T Lee, Ling Li, Patricia A Brafford, et al.
BMC Medical Research Methodology|July 9, 2025
A framework for clinical care pathway renewal: an example from inflammatory bowel diseaseK D Chappell, L Olayinka, R Sutton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2013
The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cellsClemens Krepler, Srinivas K Chunduru, Molly B Halloran, et al.
Pageof 3